Loading...
XKRX
161890
Market cap1.18bUSD
Apr 11, Last price  
70,900.00KRW
1D
5.51%
1Q
25.27%
Jan 2017
7.75%
IPO
151.87%
Name

Kolmar Korea Co Ltd

Chart & Performance

D1W1MN
No data to show
P/E
322.35
P/S
0.78
EPS
219.94
Div Yield, %
—
Shrs. gr., 5y
0.77%
Rev. gr., 5y
9.68%
Revenues
2.45t
+13.75%
282,228,682,720461,252,659,670535,846,082,250667,469,194,150821,615,970,1901,357,865,265,1901,540,720,628,9601,322,081,317,6601,586,332,710,2501,865,731,523,0302,155,675,927,4202,452,063,980,460
Net income
90.07b
+1,634.92%
14,060,089,74032,806,096,79045,479,278,76053,079,052,67047,261,870,19042,307,152,80029,057,851,620160,269,947,48035,811,330,530-4,101,004,6805,191,815,10090,074,028,300
CFO
215.38b
+91.89%
24,947,363,78034,419,374,90049,420,179,91038,213,822,3405,386,484,25062,759,621,620164,842,538,880121,463,641,010-3,122,843,67090,811,567,580112,241,475,350215,382,940,700
Dividend
Dec 27, 2023600 KRW/sh
Earnings
May 08, 2025

Profile

Kolmar Korea Co., Ltd. researches, develops, produces, and sells beauty and health products in South Korea and internationally. It offers various cosmetic products, including skin care, makeup, baby, hair care, and body care products, as well as perfume, functional cosmetics, and qusi drugs. The company also provides prescription, over-the-counter, and bioequivalent drugs; drugs for dermatology and circulatory system; ointment and external, and oral solutions; and oral solids. In addition, it offers health functional food comprising health supplements; ingredients; special purpose food; and individually recognized health supplements. The company was founded in 2012 and is headquartered in Sejong, South Korea.
URL
https://www.kolmar.co.kr/
IPO date
Oct 19, 2012
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,452,063,980
13.75%
2,155,675,927
15.54%
1,865,731,523
17.61%
Cost of revenue
2,012,569,146
1,792,555,437
1,600,018,989
Unusual Expense (Income)
NOPBT
439,494,834
363,120,490
265,712,534
NOPBT Margin
17.92%
16.84%
14.24%
Operating Taxes
14,448,917
9,199,172
21,074,800
Tax Rate
3.29%
2.53%
7.93%
NOPAT
425,045,917
353,921,318
244,637,735
Net income
90,074,028
1,634.92%
5,191,815
-226.60%
(4,101,005)
-111.45%
Dividends
(19,379,070)
(16,606,635)
(11,751,190)
Dividend yield
1.49%
1.35%
1.21%
Proceeds from repurchase of equity
(21,545)
(24,180,981)
BB yield
0.00%
2.48%
Debt
Debt current
799,010,001
853,960,460
532,079,572
Long-term debt
405,690,975
314,853,160
589,137,676
Deferred revenue
1,483,759
1,214,795
514,354
Other long-term liabilities
13,537,321
9,676,844
8,248,182
Net debt
1,008,286,343
815,721,035
867,396,644
Cash flow
Cash from operating activities
215,382,941
112,241,475
90,811,568
CAPEX
(247,173,428)
(124,728,900)
(57,453,104)
Cash from investing activities
(205,249,105)
(155,684,341)
(145,246,118)
Cash from financing activities
(8,409,315)
82,026,021
FCF
212,527,584
278,512,494
63,974,523
Balance
Cash
208,520,767
280,261,977
297,396,654
Long term investments
(12,106,134)
72,830,608
(43,576,051)
Excess cash
73,811,433
245,308,789
160,534,027
Stockholders' equity
1,212,813,907
1,156,282,905
1,226,761,690
Invested Capital
2,597,187,074
2,287,005,307
2,358,934,023
ROIC
17.40%
15.24%
10.95%
ROCE
16.21%
14.08%
10.33%
EV
Common stock shares outstanding
23,623
22,881
22,881
Price
55,100.00
2.80%
53,600.00
25.82%
42,600.00
5.84%
Market cap
1,301,613,911
6.13%
1,226,431,248
25.82%
974,738,268
5.84%
EV
3,022,997,389
2,812,120,303
2,647,511,514
EBITDA
531,469,149
456,848,593
341,137,453
EV/EBITDA
5.69
6.16
7.76
Interest
46,516,744
45,064,091
32,694,822
Interest/NOPBT
10.58%
12.41%
12.30%